These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 18337845)

  • 1. [Is the latest always the best?].
    Rygnestad T; Slørdal L
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):680. PubMed ID: 18337845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Who will choose patients' medication in the future? Independent information must be strengthened II].
    Liedholm H; Linné AB; Ekedahl A
    Lakartidningen; 1996 Jun; 93(24):2315-7. PubMed ID: 8684030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug handling is unreasonable in Sweden].
    Fichtelius KE
    Lakartidningen; 1993 Dec; 90(50):4534. PubMed ID: 8264284
    [No Abstract]   [Full Text] [Related]  

  • 4. [A serious discussion concerning p-pills is needed].
    Samuelsson E; Hägg S; Håkanson J
    Lakartidningen; 1997 Jul; 94(28-29):2530. PubMed ID: 9254311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Should it be possible to search original preparations via pharmacies' computers?].
    Gullberg R
    Lakartidningen; 2002 Dec; 99(49):5011. PubMed ID: 12522996
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prohibited marketing and shift in meaning of indications--a case for the IGM].
    Perman E
    Lakartidningen; 2003 Jul; 100(28-29):2378-9. PubMed ID: 12899031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Offer for better drug information].
    Højgaard L
    Ugeskr Laeger; 1994 Feb; 156(6):832-3. PubMed ID: 8016994
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of information and of decision-making in the field of supply and consumption of medical preparations.
    Kis GS
    Sante Publique (Bucur); 1980; 23(2):73-80. PubMed ID: 7209743
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug company influence.
    Mittman D
    Am J Nurs; 2009 Mar; 109(3):14; author reply 14. PubMed ID: 19240469
    [No Abstract]   [Full Text] [Related]  

  • 10. Pill splitting.
    Harv Mens Health Watch; 2008 Nov; 13(4):7. PubMed ID: 19024770
    [No Abstract]   [Full Text] [Related]  

  • 11. Marketing drugs in the Third World.
    Lancet; 1986 Jul; 2(8500):222. PubMed ID: 2873468
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug information received from drug company representatives at a health center].
    Giménez González M; Delas Ramírez FJ; Gómez Portela JL; Quirós Bauset C
    Aten Primaria; 1994 Mar; 13(5):265-6. PubMed ID: 7654927
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient assistance programs: information is not our enemy.
    Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH
    Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896
    [No Abstract]   [Full Text] [Related]  

  • 14. Hotel-based medicine.
    Greenwald R
    J Rheumatol; 2009 Feb; 36(2):456; author reply 456-7. PubMed ID: 19208583
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug information--national decision needed].
    Ohman U; Nilsson A
    Lakartidningen; 2008 Jul 9-22; 105(28-29):2038. PubMed ID: 18711826
    [No Abstract]   [Full Text] [Related]  

  • 16. Purely medicinal?
    Richards T
    BMJ; 2008 Mar; 336(7646):693. PubMed ID: 18369224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug information on better conditions].
    Rolfs M; Johansson P
    Lakartidningen; 2009 Mar 4-10; 106(10):655. PubMed ID: 19418682
    [No Abstract]   [Full Text] [Related]  

  • 19. Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
    Kale SA; Barkin RL
    Compr Ther; 2009; 35(2):68-71. PubMed ID: 19618754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmaceutical consultants don't give neutral information].
    Reseland S
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2620. PubMed ID: 19023368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.